Silexion Therapeutics Corp
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−25.2127 USD
−16.44 M USD
0.00 USD
2.31 M
About Silexion Therapeutics Corp
Sector
Industry
CEO
Ilan Hadar
Website
Headquarters
Ramat-Gan
Founded
2008
Identifiers
3
ISIN KYG1281K1141
Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
Displays a symbol's price movements over previous years to identify recurring trends.